Comparision of Regulatory Action of cAMP and cGMP on the Activation of Neutrophil Responses

Comparision of Regulatory Action of cAMP and cGMP on the Activation of Neutrophil Responses

<P> The regulatory role of cyclic nucleotides in the expression of neutrophil responses has been examined. fMLP-stimulated superoxide production in neutrophils was inhibited by dibutyryl adenosine 3 ,5 -cyclic monophosphate (DBcAMP), histamine, adenosine&#8290;theophylline, cAMP elevating agents, and 8-bromoguanosine 3 ,5 -cyclic monophosphate (8-BrcGMP) and sodium nitroprusside, cGMP elevating agents. Staurosporine, a protein kinase C inhibitor, genistein, a protein tyrosine kinase inhibitor and chlorpromazine, a calmodulin inhibitor, inhibited superoxide production by fMLP, but they did not further affect the action of DBcAMP on the stimulatory action of fMLP. DBcAMP, histamine, adenosine&#8290;theophylline and genistein inhibited myeloperoxidease release evoked by fMLP, whereas BrcGMP, sodium nitroprusside and staurosporine did not affect it. The elevation of [Ca<SUP>2&#8290;</SUP>]<SUB>i</SUB> evoked by fMLP was inhibited by genistein and chlorpromazine but was not affected by staurosporine. DBcAMP exerted little effect on the initial peak in [Ca<SUP>2&#8290;</SUP>]<SUB>i</SUB> response to fMLP but effectively inhibited the sustained rise. On the other hand, BrcGMP significantly inhibited both phases. fMLP-induced Mn<SUP>2&#8290;</SUP> influx was inhibited by either DBcAMP or BrcGMP. These results suggest that fMLP-stimulated neutrophil responses may be regulated by cAMP more than cGMP. cAMP and cGMP appear not affect stimulated responses by direct protein kinase C activation. Their regulatory action on the stimulated neutrophil responses may be not influenced by other activation processes.